Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Hinge Health Inc. stock logo
HNGE
Hinge Health
$88.44
+0.6%
$79.99
$30.08
$93.13
$7.14B1.311.75 million shs1.12 million shs
HealthEquity, Inc. stock logo
HQY
HealthEquity
$102.79
+0.4%
$95.71
$72.76
$107.62
$8.76B0.21666,701 shs643,108 shs
Premier, Inc. stock logo
PINC
Premier
$50.05
+77.7%
$28.20
$19.63
$28.79
$2.33B0.641.67 million shs2.06 million shs
Tempus AI, Inc. stock logo
TEM
Tempus AI
$49.36
-4.4%
$51.86
$40.77
$104.32
$9.32B3.585.11 million shs3.50 million shs
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Hinge Health Inc. stock logo
HNGE
Hinge Health
-0.44%-3.88%+0.81%+60.10%+48.47%
HealthEquity, Inc. stock logo
HQY
HealthEquity
-2.29%-4.18%+4.77%+20.89%+13.84%
Premier, Inc. stock logo
PINC
Premier
-0.09%+0.25%-0.06%+77.21%+100.72%
Tempus AI, Inc. stock logo
TEM
Tempus AI
-0.88%-6.21%-1.58%+13.42%-30.01%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Hinge Health Inc. stock logo
HNGE
Hinge Health
$88.44
+0.6%
$79.99
$30.08
$93.13
$7.14B1.311.75 million shs1.12 million shs
HealthEquity, Inc. stock logo
HQY
HealthEquity
$102.79
+0.4%
$95.71
$72.76
$107.62
$8.76B0.21666,701 shs643,108 shs
Premier, Inc. stock logo
PINC
Premier
$50.05
+77.7%
$28.20
$19.63
$28.79
$2.33B0.641.67 million shs2.06 million shs
Tempus AI, Inc. stock logo
TEM
Tempus AI
$49.36
-4.4%
$51.86
$40.77
$104.32
$9.32B3.585.11 million shs3.50 million shs
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Hinge Health Inc. stock logo
HNGE
Hinge Health
-0.44%-3.88%+0.81%+60.10%+48.47%
HealthEquity, Inc. stock logo
HQY
HealthEquity
-2.29%-4.18%+4.77%+20.89%+13.84%
Premier, Inc. stock logo
PINC
Premier
-0.09%+0.25%-0.06%+77.21%+100.72%
Tempus AI, Inc. stock logo
TEM
Tempus AI
-0.88%-6.21%-1.58%+13.42%-30.01%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Hinge Health Inc. stock logo
HNGE
Hinge Health
2.83
Moderate Buy$100.5713.72% Upside
HealthEquity, Inc. stock logo
HQY
HealthEquity
2.77
Moderate Buy$110.937.92% Upside
Premier, Inc. stock logo
PINC
Premier
1.86
Reduce$26.46-47.14% Downside
Tempus AI, Inc. stock logo
TEM
Tempus AI
2.41
Hold$64.9231.53% Upside

Current Analyst Ratings Breakdown

Latest PINC, TEM, HQY, and HNGE Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/12/2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
UpgradeSell (E+)Sell (D-)
8/11/2026
Hinge Health Inc. stock logo
HNGE
Hinge Health
DowngradeStrong-BuyHold
8/10/2026
Hinge Health Inc. stock logo
HNGE
Hinge Health
Boost Price TargetBuy$85.00 ➝ $112.00
8/5/2026
Hinge Health Inc. stock logo
HNGE
Hinge Health
Reiterated RatingOutperform$105.00
8/5/2026
Hinge Health Inc. stock logo
HNGE
Hinge Health
Boost Price TargetOutperform$75.00 ➝ $110.00
8/5/2026
Hinge Health Inc. stock logo
HNGE
Hinge Health
Set Price Target$105.00
8/5/2026
Hinge Health Inc. stock logo
HNGE
Hinge Health
Set Price Target$96.00
8/5/2026
Hinge Health Inc. stock logo
HNGE
Hinge Health
Boost Price TargetOverweight$97.00 ➝ $100.00
8/5/2026
Hinge Health Inc. stock logo
HNGE
Hinge Health
Boost Price TargetOverweight$90.00 ➝ $103.00
8/5/2026
Hinge Health Inc. stock logo
HNGE
Hinge Health
Boost Price TargetMarket Outperform$96.00 ➝ $107.00
8/5/2026
Hinge Health Inc. stock logo
HNGE
Hinge Health
Boost Price TargetBuy$76.00 ➝ $97.00
(Data available from 8/18/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Hinge Health Inc. stock logo
HNGE
Hinge Health
$587.86M12.14N/AN/A$2.26 per share39.13
HealthEquity, Inc. stock logo
HQY
HealthEquity
$1.31B6.54$5.18 per share19.85$24.66 per share4.17
Premier, Inc. stock logo
PINC
Premier
$1.00B4.11$5.14 per share9.74$18.51 per share2.70
Tempus AI, Inc. stock logo
TEM
Tempus AI
$1.43B6.22N/AN/A$2.76 per share17.88
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Hinge Health Inc. stock logo
HNGE
Hinge Health
-$528.26M$1.2869.0965.03N/A15.15%51.60%14.16%N/A
HealthEquity, Inc. stock logo
HQY
HealthEquity
$215.20M$2.6738.5022.591.7617.25%14.75%9.22%8/27/2026 (Estimated)
Premier, Inc. stock logo
PINC
Premier
$20.27M-$0.27N/A37.63N/A-3.28%6.84%3.48%N/A
Tempus AI, Inc. stock logo
TEM
Tempus AI
-$245.03M-$1.44N/AN/AN/A-17.77%-50.28%-10.33%11/3/2026 (Estimated)

Latest PINC, TEM, HQY, and HNGE Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/27/2026Q2 2027
HealthEquity, Inc. stock logo
HQY
HealthEquity
$1.19N/AN/AN/A$349.22 millionN/A
8/4/2026Q2 2026
Hinge Health Inc. stock logo
HNGE
Hinge Health
$0.28$0.59+$0.31$0.52N/A$212.82 million
7/30/2026Q2 2026
Tempus AI, Inc. stock logo
TEM
Tempus AI
-$0.1428-$0.04+$0.1028$0.03$379.69 million$382.49 million
5/28/2026Q1 2027
HealthEquity, Inc. stock logo
HQY
HealthEquity
$1.11$1.24+$0.13$0.82$352.02 million$354.64 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Hinge Health Inc. stock logo
HNGE
Hinge Health
N/AN/AN/AN/AN/A
HealthEquity, Inc. stock logo
HQY
HealthEquity
N/AN/AN/AN/AN/A
Premier, Inc. stock logo
PINC
Premier
$0.841.68%N/AN/A N/A
Tempus AI, Inc. stock logo
TEM
Tempus AI
N/AN/AN/AN/AN/A

Latest PINC, TEM, HQY, and HNGE Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/20/2026
Premier, Inc. stock logo
PINC
Premier
monthly$0.21015.06%7/31/20267/31/20268/4/2026
6/29/2026
Premier, Inc. stock logo
PINC
Premier
monthly$0.17484.19%6/30/20266/30/20267/2/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Hinge Health Inc. stock logo
HNGE
Hinge Health
N/A
1.34
1.30
HealthEquity, Inc. stock logo
HQY
HealthEquity
0.46
3.44
3.44
Premier, Inc. stock logo
PINC
Premier
N/A
0.62
0.62
Tempus AI, Inc. stock logo
TEM
Tempus AI
3.06
3.30
3.16

Institutional Ownership

CompanyInstitutional Ownership
Hinge Health Inc. stock logo
HNGE
Hinge Health
N/A
HealthEquity, Inc. stock logo
HQY
HealthEquity
99.55%
Premier, Inc. stock logo
PINC
Premier
74.41%
Tempus AI, Inc. stock logo
TEM
Tempus AI
24.22%

Insider Ownership

CompanyInsider Ownership
Hinge Health Inc. stock logo
HNGE
Hinge Health
18.92%
HealthEquity, Inc. stock logo
HQY
HealthEquity
1.60%
Premier, Inc. stock logo
PINC
Premier
0.96%
Tempus AI, Inc. stock logo
TEM
Tempus AI
24.26%
CompanyEmployeesShares OutstandingFree FloatOptionable
Hinge Health Inc. stock logo
HNGE
Hinge Health
1,43780.69 million65.43 millionN/A
HealthEquity, Inc. stock logo
HQY
HealthEquity
2,81483.60 million82.26 millionOptionable
Premier, Inc. stock logo
PINC
Premier
2,70082.55 million81.76 millionNo Data
Tempus AI, Inc. stock logo
TEM
Tempus AI
3,800180.44 million136.66 millionN/A

Recent News About These Companies

Tempus AI: The Data Flywheel Has Started Spinning

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Hinge Health stock logo

Hinge Health NYSE:HNGE

$88.44 +0.57 (+0.65%)
Closing price 03:59 PM Eastern
Extended Trading
$89.00 +0.56 (+0.63%)
As of 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients. We have designed our platform to address a broad spectrum of MSK care—from acute injury, to chronic pain, to post-surgical rehabilitation. Members receive personalized and largely automated MSK care through our AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device, all designed and monitored by our AI-supported care team of licensed physical therapists, physicians, and board-certified health coaches. Our platform can improve pain and function and reduce the need for surgeries, all while driving health equity by allowing members to engage in their exercise therapy sessions from anywhere and embrace movement as a way of life. There is no shortage of new technologies in the healthcare industry, yet the cost of care continues to rise. In other industries, the launch of new technologies has generally improved end-user experiences and lowered costs. In healthcare, however, new technologies have not always been successful in lowering the cost of care or improving clinical outcomes. We believe there are two key reasons for healthcare’s idiosyncratic response to technology: • Automating most aspects of care is difficult because so many healthcare interventions involve unstructured physical tasks. • The current framework for healthcare reimbursement has specific pathways to pay for care, which means new technologies are constrained to deliver within this framework. At Hinge Health, we have taken these challenges head-on. To address the automation of care, we have weaved together AI-enabled capabilities - such as our AI-powered motion tracking technology, TrueMotion, our proprietary FDA-cleared wearable device, Enso, and our AI-supported care team - to deliver scalable and personalized MSK care. According to our estimates based on data from 2024, our platform reduced the number of human care team hours associated with traditional physical therapy by approximately 95%. We have done this while improving our high member satisfaction over time. To address healthcare reimbursement constraints, we developed novel billing methods for our innovative technology by both directly selling to employers while also partnering with health plans, pharmacy benefit managers (“PBMs”), third-party administrators (“TPAs”), and other ecosystem entities to efficiently provide our platform to clients and members. While the MSK market is massive, existing solutions have fallen short as they are often expensive, ineffective, inconvenient to access, and delivered in a one-to-one or few-to-one care setting. Effective MSK care should be engaging, easy to use, and accessible anytime, anywhere. We developed Hinge Health to be simple and accessible, complete, personalized, and scalable. • Simple and accessible: We provide members access to our platform at no direct cost to them and without a copay or deductible. Members can access our broad spectrum of MSK care through a single on-demand app, designed to provide an engaging, seamless, and convenient digital experience whenever and wherever the member chooses. Potential members can complete a simple intake form, download the app, and start exercises soon thereafter. During the year ended December 31, 2024, approximately 64% of members were onboarded on the same day they completed their intake form, and approximately 75% of members were onboarded within the first week. • Complete: Our platform offers a wide range of support with multiple programs across many affected areas to provide a continuum of care from prevention to treatment of acute injury and chronic pain, as well as surgery decision support and post-surgical recovery. We also offer non-addictive and non-invasive pain relief via electrostimulation through our proprietary FDA-cleared wearable device, Enso, that is seamlessly integrated into our platform. • Personalized: Our platform delivers smarter care through AI and machine learning. Our AI model is trained on a large, proprietary MSK data set, and our technology is continuously learning and improving as each new member enrolls and engages with our programs, which creates a positive feedback loop. As of March 31, 2025, we had treated over one million members and our programs had tracked over 74 million activity sessions and 32 million member-reported outcome logs. We focus on personalization to keep members moving: from customized care plans to real-time in-app exercise feedback based on the member’s input and our proprietary motion tracking technology. • Scalable: Our AI-powered motion tracking technology, TrueMotion, allows us to deliver scalable and largely automated care. According to our estimates based on data from 2024, our platform reduced the number of human care team hours associated with traditional physical therapy by approximately 95%. While most of our programs provide members with access to a dedicated care team, our technology automates most aspects of care delivery while allowing our members to progress through their exercise therapy sessions on their own time. We have developed an efficient go-to-market model by working directly with our partners and clients. We seek to be the best solution on the market, the most validated solution on the market, and the easiest to buy. Our clients are primarily self-insured employers and include many of the nation’s leading enterprises across a broad range of industries and sizes. Within this segment, we also serve many public sector self-insured employers, such as state and local city governments and labor unions. In most instances, we partner with clients’ health plans, TPAs, PBMs, or other ecosystem entities to reduce the friction of contracting, procurement, security and IT reviews, onboarding, and billing. We are also in the early stages of expanding to serve health plans’ fully-insured and Medicare Advantage populations and federal insurance plans. As of December 31, 2024, we had approximately 20 million contracted lives across more than 2,250 clients. We had active client agreements with 49% of the Fortune 100 companies and 42% of the Fortune 500 companies, as of December 31, 2024. Despite this progress, our current contracted lives only represent 5% of our total addressable market. We believe that we grow efficiently because of our scalable, repeatable go-to-market model. We sell through our direct sales force and our partners. Once we contract with a client, we are most often the sole digital MSK care provider offered to their contracted lives. Our average contract term is three years. For the term of each contract, we are able to enroll, engage, and re-engage the client’s eligible lives, driving a recurring, repeatable revenue model, which is demonstrated in our net dollar retention of 117% as of December 31, 2024. Our 12-month client retention rate was 98% as of December 31, 2024. Additionally, we have a high level of client satisfaction, as shown by our client net promoter score (“NPS”) of 87 as of October 31, 2024. We also invested early in building our partner network. As of March 31, 2025, we had over 50 partners. Our partners include the five largest national health plans by self-insured lives, and the top three PBMs by market share. As of that date, we had retained 100% of our partners that we chose to work with since inception, excluding partners who were acquired. We have experienced significant growth since our inception, with a recurring revenue business model. As of December 31, 2024, we had over 532,000 members and more than 2,250 clients, compared to approximately 371,000 members and approximately 1,650 clients as of December 31, 2023. Our principal executive offices are located in San Francisco, California.

HealthEquity stock logo

HealthEquity NASDAQ:HQY

$102.79 +0.46 (+0.45%)
Closing price 04:00 PM Eastern
Extended Trading
$102.21 -0.58 (-0.56%)
As of 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.

Premier stock logo

Premier NASDAQ:PINC

Premier, Inc., together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions. This segment also provides the ASCENDrive programs for members to receive group purchasing programs, tiers, and prices; SURPASS Performance Group services; and STOCKD, an e-commerce platform, as well as direct sourcing business; SaaS informatics products; supply chain co-management services; purchased services contracts; direct sourcing solutions; and supply chain resiliency programs. The Performance Services segment provides technology and services platform with offerings that help optimize performance in three main areas, including clinical intelligence, margin improvement, and value-based care under the PINC AI brand; third party administrator services and management of health benefit programs under the Contigo Health brand; and digital invoicing and payables services that offers financial support services to healthcare product suppliers and service providers under the Remitra brand. The company was incorporated in 2013 and is based in Charlotte, North Carolina.

Tempus AI stock logo

Tempus AI NASDAQ:TEM

$49.36 -2.28 (-4.42%)
Closing price 04:00 PM Eastern
Extended Trading
$48.85 -0.51 (-1.04%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO.